STOCK TITAN

BlackRock discloses 4.12M BBBY shares, 7.2% ownership in 13G/A

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

BlackRock, Inc. filed Amendment No. 5 to Schedule 13G reporting beneficial ownership of 4,123,240 shares of Bed Bath & Beyond, Inc. common stock, representing 7.2% of the class as of 09/30/2025. BlackRock reported sole voting power over 4,025,167 shares and sole dispositive power over 4,123,240 shares, with no shared voting or dispositive power.

BlackRock certified the holdings were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing is signed by a Managing Director and includes a Power of Attorney exhibit.

Positive

  • None.

Negative

  • None.





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



BlackRock, Inc.
Signature:Spencer Fleming
Name/Title:Managing Director
Date:10/17/2025
Exhibit Information

Exhibit 24: Power of Attorney Exhibit 99: Item 7

FAQ

What stake in BBBY did BlackRock report on Schedule 13G/A?

BlackRock reported beneficial ownership of 4,123,240 shares, or 7.2% of Bed Bath & Beyond’s common stock.

As of what date are BlackRock’s BBBY holdings reported?

The holdings are reported as of 09/30/2025.

How many BBBY shares does BlackRock have sole voting power over?

BlackRock reported sole voting power over 4,025,167 shares.

How many BBBY shares does BlackRock have sole dispositive power over?

BlackRock reported sole dispositive power over 4,123,240 shares.

Did BlackRock indicate any intent to influence control of BBBY?

No. BlackRock certified the securities were acquired and are held in the ordinary course of business, not to influence control.

What is the amendment number of this Schedule 13G filing?

This is Amendment No. 5 to BlackRock’s Schedule 13G.

Who signed the filing on behalf of BlackRock?

The filing was signed by Spencer Fleming, Managing Director.